Literature DB >> 23806527

Histologic prognostic factors associated with chromosomal imbalances in a contemporary series of 89 clear cell renal cell carcinomas.

Julien Dagher1, Frederic Dugay, Gregory Verhoest, Florian Cabillic, Sylvie Jaillard, Catherine Henry, Yannick Arlot-Bonnemains, Karim Bensalah, Emmanuel Oger, Cecile Vigneau, Nathalie Rioux-Leclercq, Marc-Antoine Belaud-Rotureau.   

Abstract

Clear cell renal cell carcinoma (ccRCC) is the most common type of renal cancer. The aim of this study was to define specific chromosomal imbalances in ccRCC that could be related to clinical or histologic prognostic factors. Tumors and karyotypes of 89 patients who underwent nephrectomy for ccRCC were analyzed from April 2009 to July 2012. The mean number of chromosomal aberrations was significantly higher (7.8; P < .05) in Fuhrman grade 4 (F4) than in F3 (4) and F2 (3.4) cases. The results were similar, considering separately the mean number of chromosomal losses and gains. The F4 cases had a distinct pattern with more frequent losses of chromosomes 9, 13, 14, 18, 21, 22, and Y and gains of chromosome 20. Necrosis was associated with losses of chromosomes 7, 9, 18, and 22; sarcomatoid component, losses of chromosomes 7, 9, and 14 and gains of 20; and T stage, losses of chromosomes 18 and Y. After multivariate analysis, renal fat invasion, renal vein emboli, and microscopic vascular invasion were, respectively, associated with losses of chromosomes 13 and Y, loss of chromosome 13, and loss of chromosome 14 and gains of chromosomes 7 and 20. F4 was independently associated with losses of chromosomes 9 and Y; sarcomatoid component, loss of chromosome 9 and gain of 20; necrosis, loss of chromosome 18; and T stage, loss of chromosome Y. These chromosomal imbalances can be detected routinely by karyotype or fluorescence in situ hybridization analyses to stratify patients for risk of progression.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Keywords:  Chromosomal imbalances; Clear cell renal cell carcinoma; Fuhrman grade; Karyotype; Necrosis; Prognosis; Sarcomatoid component

Mesh:

Year:  2013        PMID: 23806527     DOI: 10.1016/j.humpath.2013.03.018

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  9 in total

1.  Sarcomatoid Renal Cell Carcinoma Has a Distinct Molecular Pathogenesis, Driver Mutation Profile, and Transcriptional Landscape.

Authors:  Zixing Wang; Tae Beom Kim; Bo Peng; Jose Karam; Chad Creighton; Aron Joon; Fumi Kawakami; Patricia Trevisan; Eric Jonasch; Chi-Wan Chow; Jaime Rodriguez Canales; Pheroze Tamboli; Nizar Tannir; Christopher Wood; Federico Monzon; Keith Baggerly; Marileila Varella-Garcia; Bogdan Czerniak; Ignacio Wistuba; Gordon Mills; Kenna Shaw; Ken Chen; Kanishka Sircar
Journal:  Clin Cancer Res       Date:  2017-07-14       Impact factor: 12.531

2.  Clear cell renal cell carcinoma: a comparative study of histological and chromosomal characteristics between primary tumors and their corresponding metastases.

Authors:  Julien Dagher; Solène-Florence Kammerer-Jacquet; Frédéric Dugay; Marion Beaumont; Alexandra Lespagnol; Laurence Cornevin; Grégory Verhoest; Karim Bensalah; Nathalie Rioux-Leclercq; Marc-Antoine Belaud-Rotureau
Journal:  Virchows Arch       Date:  2017-05-10       Impact factor: 4.064

3.  Genomic Copy Number Alterations in Renal Cell Carcinoma with Sarcomatoid Features.

Authors:  Timothy Ito; Jianming Pei; Essel Dulaimi; Craig Menges; Philip H Abbosh; Marc C Smaldone; David Y T Chen; Richard E Greenberg; Alexander Kutikov; Rosalia Viterbo; Robert G Uzzo; Joseph R Testa
Journal:  J Urol       Date:  2015-11-18       Impact factor: 7.450

4.  Proteogenomic analysis of human chromosome 9-encoded genes from human samples and lung cancer tissues.

Authors:  Jung-Mo Ahn; Min-Sik Kim; Yong-In Kim; Seul-Ki Jeong; Hyoung-Joo Lee; Sun Hee Lee; Young-Ki Paik; Akhilesh Pandey; Je-Yoel Cho
Journal:  J Proteome Res       Date:  2013-12-06       Impact factor: 4.466

Review 5.  Significance of chromosome 9p status in renal cell carcinoma: a systematic review and quality of the reported studies.

Authors:  Ismail El-Mokadem; John Fitzpatrick; Bhavan Rai; J Cunningham; Norman Pratt; Stewart Fleming; Ghulam Nabi
Journal:  Biomed Res Int       Date:  2014-04-30       Impact factor: 3.411

6.  Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery.

Authors:  I El-Mokadem; J Fitzpatrick; J Bondad; P Rauchhaus; J Cunningham; N Pratt; S Fleming; G Nabi
Journal:  Br J Cancer       Date:  2014-08-19       Impact factor: 7.640

7.  Biphasic components of sarcomatoid clear cell renal cell carcinomas are molecularly similar to each other, but distinct from, non-sarcomatoid renal carcinomas.

Authors:  Kanishka Sircar; Suk-Young Yoo; Tadeusz Majewski; Khalida Wani; Lalit R Patel; Horatiu Voicu; Wandaliz Torres-Garcia; Roel G W Verhaak; Nizar Tannir; Jose A Karam; Eric Jonasch; Christopher G Wood; Pheroze Tamboli; Keith A Baggerly; Kenneth D Aldape; Bogdan Czerniak
Journal:  J Pathol Clin Res       Date:  2015-07-07

Review 8.  The Challenges of Chromosome Y Analysis and the Implications for Chronic Kidney Disease.

Authors:  Kerry Anderson; Marisa Cañadas-Garre; Robyn Chambers; Alexander Peter Maxwell; Amy Jayne McKnight
Journal:  Front Genet       Date:  2019-09-04       Impact factor: 4.599

9.  A non-diploid DNA status is linked to poor prognosis in renal cell cancer.

Authors:  Franziska Büscheck; Christoph Fraune; Martina Kluth; Maximilian Lennartz; Ronald Simon; Claudia Hube-Magg; Christian Morlock; Silvano Barbieri; Carolin Wahl; Christian Eichelberg; Christina Möller-Koop; Doris Höflmayer; Corinna Wittmer; Waldemar Wilczak; Guido Sauter; Margit Fisch; Till Eichenauer; Michael Rink
Journal:  World J Urol       Date:  2020-05-02       Impact factor: 4.226

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.